Korean venture capital E& leads merger of clinical stage biotech firms
E& Investment, a South Korean venture capital that specializes in the bio and health care sectors, said Thursday that NeuroBo Pharmaceutical, in which the company owns a 40 percent stake, had acquired a US COVID-19 treatment developer. NeuroBo, a Nasdaq-listed clinical-stage biotechnology company,...